SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Choo Q.L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., Houghton M. (1989) Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244: 35962.
  • 2
    Chisari F.V. (2005) Unscrambling hepatitis C virus-host interactions. Nature 436: 93032.
  • 3
    Alter M.J. (2007) Epidemiology of hepatitis C virus infection. World J Gastroenterol 13: 2436441.
  • 4
    Feld J.J., Hoofnagle J.H. (2005) Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature 436: 96772.
  • 5
    Kremsdorf D., Brezillon N. (2007) New animal models for hepatitis C viral infection and pathogenesis studies. World J Gastroenterol 13: 2427435.
  • 6
    Wu G.Y., Konishi M., Walton C.M., Olive D., Hayashi K., Wu C.H. (2005) A novel immunocompetent rat model of HCV infection and hepatitis. Gastroenterology 128: 1416423.
  • 7
    Ilan E., Arazi J., Nussbaum O., Nussbaum O., Zauberman A., Eren R., Lubin I., Neville L., Ben-Moshe O., Kischitzky A., Litchi A., Margalit I., Gopher J., Mounir S., Cai W., Daudi N., Eid A., Jurim O., Czerniak A., Galun E., Dagan S. (2002) The hepatitis C virus (HCV)-Trimera mouse: a model for evaluation of agents against HCV. J Infect Dis 185: 15361.
  • 8
    Eren R., Landstein D., Terkieltaub D., Nussbaum O., Zauberman A., Ben-Porath J., Gopher J., Buchnick R., Kovjazin R., Rosenthal-Galili Z., Aviel S., Ilan E., Shoshany Y., Neville L., Waisman T., Ben-Moshe O., Kischitsky A., Foung S.K., Keck Z.Y., Pappo O., Eid A., Jurim O., Zamir G., Galun E., Dagan S. (2006) Preclinical evaluation of two neutralizing human monoclonal antibodies against hepatitis C virus (HCV): a potential treatment to prevent HCV reinfection in liver transplant patients. J Virol 80: 2654664.
  • 9
    Mercer D.F., Schiller D.E., Elliott J.F., Douglas D.N., Hao C., Rinfret A., Addison W.R., Fischer K.P., Churchill T.A., Lakey J.R., Tyrrell D.L., Kneteman N.M. (2001) Hepatitis C virus replication in mice with chimeric human livers. Nat Med 7: 92733.
  • 10
    Meuleman P., Libbrecht L., De Vos R., De Hemptinne B., Gevaert K., Vandekerckhove J., Roskams T., Leroux-Roels G. (2005) Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera. Hepatology 41: 84756.
  • 11
    Kneteman N.M., Weiner A.J., O'Connell J., Collett M., Gao T., Aukerman L., Kovelsky R., Ni Z.J., Zhu Q., Hashash A., Kline J., Hsi B., Schiller D., Douglas D., Tyrrell D.L., Mercer D.F. (2006) Anti-HCV therapies in chimeric scid-Alb/uPA mice parallel outcomes in human clinical application. Hepatology 43: 1346353.
  • 12
    Bassett S.E., Brasky K.M., Lanford R.E. (1998) Analysis of hepatitis C virus-inoculated chimpanzees reveals unexpected clinical profiles. J Virol 72: 2589599.
  • 13
    Cohen J. (2007) Animal studies: NIH to end chimp breeding for research. Science 316: 1265.
  • 14
    Ambrose Z., KewalRamani V.N., Bieniasz P.D., Hatziioannou T. (2007) HIV/AIDS: in search of an animal model. Trends Biotech 25: 33337.
  • 15
    Lackner A.A., Veazey R.S. (2007) Current concepts in AIDS pathogenesis: insights from the SIV/macaque model. Annu Rev Med 58: 46176.
  • 16
    Deinhardt F., Holmes A.W., Capps R.B., Popper H. (1967) Studies on the transmission of human viral hepatitis to marmoset monkeys. I. Transmission of disease, serial passages, and description of liver lesions. J Exp Med 125: 67388.
  • 17
    Simons J.N., Pilot-Matias T.J., Leary T.P., Dawson G.J., Desai S.M., Schlauder G.G., Muerhoff A.S., Erker J.C., Buijk S.L., Chalmers M.L. (1995) Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci USA 92: 3401405.
  • 18
    Schaluder G.G., Dawson G.J., Simons J.N., Pilot-Matias T.J., Gutierrez R.A., Heynen C.A., Knigge M.F., Kurpiewski G.S., Buijk S.L., Leary T.P., Muerhoff A.S., Desai S.M., Mushahwar I.K. (1995) Molecular and serologic analysis in the transmission of the GB hepatitis agents. J Med Virol 46: 8190.
  • 19
    Bukh J., Apgar C.L., Govindarajan S., Purcell R.H. (2001) Host range studies of GB virus-B hepatitis agent, the closest relative of hepatitis C virus, in New World monkeys and chimpanzees. J Med Virol 65: 69497.
  • 20
    Beames B., Chavez D., Lanford R.E. (2001) GB virus B as a model for hepatitis C virus. ILAR J 42: 15260.
  • 21
    Bukh J., Apgar C.L., Yanagi M. (1999) Toward a surrogate model for hepatitis C virus: An infectious molecular clone of the GB virus-B hepatitis agent. Virology 262: 47078.
  • 22
    Sbardellati A., Scarselli E., Verschoor E., De Tomassi A., Lazzaro D., Traboni C. (2001) Generation of infectious and transmissible virions from a GB virus B full-length consensus clone in tamarins. J Gen Virol 82: 2437448.
  • 23
    Lanford R.E., Chavez D., Notvall L., Brasky K.M. (2003) Comparison of tamarins and marmosets as hosts for GBV-B infections and the effect of immunosuppression on duration of viremia. Virology 311: 7280.
  • 24
    Martin A., Bodola F., Sangar D.V., Goettge K., Popov V., Rijnbrand R., Lanford R.E., Lemon S.M. (2003) Chronic hepatitis associated with GB virus B persistence in a tamarin after intrahepatic inoculation of synthetic viral RNA. Proc Natl Acad Sci USA 100: 9962967.
  • 25
    Bright H., Carroll A.R., Watts P.A., Fenton R.J. (2004) Development of a GB virus B marmoset model and its validation with a novel series of hepatitis C virus NS3 protease inhibitors. J Virol 78: 2062071.
  • 26
    Jacob J.R., Lin K.C., Tennant B.C., Mansfield K.G. (2004) GB virus B infection of the common marmoset (Callithrix jacchus) and associated liver pathology. J Gen Virol 85: 2525533.
  • 27
    Nam J.H., Faulk K., Engle R.E., Govindarajan S., St Claire M., Bukh J. (2004) In vivo analysis of the 3′ untranslated region of GB virus B after in vitro mutagenesis of an infectious cDNA clone: persistent infection in a transfected tamarin. J Virol 78: 9389399.
  • 28
    Kyuregyan K.K., Poleschuk V.F., Zamyatina N.A., Isaeva O.V., Michailov M.I., Ross S., Bukh J., Roggendorf M., Viazov S. (2005) Acute GB virus B infection of marmosets is accompanied by mutations in the NS5A protein. Virus Res 114: 15457.
  • 29
    Ishii K., Iijima S., Kimura N., Lee Y.J., Ageyama N., Yagi S., Yamaguchi K., Maki N., Mori K., Yoshizaki S., Machida S., Suzuki T., Iwata N., Sata T., Terao K., Miyamura T., Akari H. (2007) GBV-B as a pleiotropic virus: distribution of GBV-B in extrahepatic tissues in vivo. Microbes Infect 9: 51521.
  • 30
    Woollard D.J., Haqshenas G., Dong X., Pratt B.F., Kent S.J., Gowans E.J. (2008) Virus-specific T-cell immunity correlates with control of GBV-B infection in marmosets. J Virol 82: 3054060.
  • 31
    Neumann-Haefelin C., Spangenberg H.C., Blum H.E., Thimme R. (2007) Host and viral factors contributing to CD8+ T cell failure in hepatitis C virus infection. World J Gastroenterol 13: 4839847.
  • 32
    Bukh J., Engle R.E., Govindarajan S., Purcell R.H. (2008) Immunity against the GBV-B hepatitis virus in tamarins can prevent productive infection following rechallenge and is long-lived. J Med Virol 80: 8794.
  • 33
    Shoukry N.H., Grakoui A., Houghton M., Chien D.Y., Ghrayeb J., Reimann K.A., Walker C.M. (2003) Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection. J Exp Med 197: 1645655.
  • 34
    Grakoui A., Shoukry N.H., Woollard D.J., Han J.H., Hanson H.L., Ghrayeb J., Murthy K.K., Rice C.M., Walker C.M. (2003) HCV persistence and immune evasion in the absence of memory T cell help. Science 302: 65962.
  • 35
    Pestka J.M., Zeisel M.B., Bläser E., Schürmann P., Bartosch B., Cosset F.L., Patel A.H., Meisel H., Baumert J., Viazov S., Rispeter K., Blum H.E., Roggendorf M., Baumert T.F. (2007) Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C. Proc Natl Acad Sci USA 104: 6025030.
  • 36
    Von Hahn T., Yoon J.C., Alter H., Rice C.M., Rehermann B., Balfe P., McKeating J.A. (2007) Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo. Gastroenterology 132: 66778.
  • 37
    Chapel H.M., Christie J.M., Peach V., Chapman R.W. (2001) Five-year follow-up of patients with primary antibody deficiencies following an outbreak of acute hepatitis C. Clin Immunol 99: 32024.
  • 38
    Yokota T., Iijima S., Kubodera T., Ishii K., Katakai Y., Ageyama N., Chen Y., Lee Y.J., Unno T., Nishina K., Iwasaki Y., Maki N., Mizusawa H., Akari H. (2007) Efficient regulation of viral replication by siRNA in a non-human primate surrogate model for hepatitis C. Biochem Biophys Res Commun 361: 294300.
  • 39
    Rijnbrand R., Yang Y., Beales L., Bodola F., Goettge K., Cohen L., Lanford R.E., Lemon S.M., Martin A. (2005) A chimeric GB virus B with 5′ nontranslated RNA sequence from hepatitis C virus causes hepatitis in tamarins. Hepatology 41: 98694.
  • 40
    Chevalier C., Saulnier A., Benureau Y., Fléchet D., Delgrange D., Colbère-Garapin F., Wychowski C., Martin A. (2007) Inhibition of hepatitis C virus infection in cell culture by small interfering RNAs. Mol Ther 15: 1452462.
  • 41
    Kamada K., Igarashi T., Martin M.A., Khamsri B., Hatcho K., Yamashita T., Fujita M., Uchiyama T., Adachi A. (2006) Generation of HIV-1 derivatives that productively infect macaque monkey lymphoid cells. Proc Natl Acad Sci USA 103: 169596964.
  • 42
    Hatziioannou T., Princiotta M., Piatak M. Jr, Yuan F., Zhang F., Lifson J.D., Bieniasz P.D. (2006) Generation of simian-tropic HIV-1 by restriction factor evasion. Science 314: 95.